We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tobacco Cessation Field Study for Adults in Recovery - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00109460
Recruitment Status : Completed
First Posted : April 28, 2005
Last Update Posted : May 13, 2015
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Inflexxion, Inc.

Brief Summary:
The project's aim is to provide a targeted, computer-administered intervention to facilitate tobacco cessation for clients in alcohol treatment. The main focus of "On the Air: A tobacco cessation program for adults in alcohol recovery" is to reduce tobacco use of clients in alcohol treatment. The program will be offered through inpatient, residential, and outpatient treatment programs to help those struggling with alcohol addiction to understand, reduce, and stop tobacco use. Clients will develop a personalized tobacco cessation plan relevant to their readiness to quit tobacco use. Based on the metaphor of a television network, this tobacco cessation program contains information on personal risks, peer stories, cravings and withdrawal, a variety of interactive activities and tools, and also motivational feedback and tips to assist in the quitting process. Phase I was a proof of concept phase, in which we delivered a prototype CD-ROM on tobacco cessation. Phase II will involve completing the development of a functional CD-ROM tool which will be subjected to a clinical field trial with a group of adults (n=196) in treatment facilities for alcohol recovery. The clinical field study will involve finalizing the content, interface, and interactive features of the CD-ROM. We will also gather satisfaction data from both clients and counselors in the various treatment facilities.

Condition or disease Intervention/treatment Phase
Tobacco Use Disorder Behavioral: Tobacco Use Disorder Phase 2

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 203 participants
Intervention Model: Crossover Assignment
Masking: Single
Official Title: Tobacco Cessation Clinical Field Study for Adults in Alcohol Abuse Recovery
Study Start Date : March 2003
Primary Completion Date : March 2005
Study Completion Date : March 2005

Primary Outcome Measures :
  1. Smoking Behavior
  2. Smoking Cessation
  3. Substance Abuse

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Carry a primary DSM-IV diagnosis of alcohol abuse or dependence
  • Smoke at least one cigarette a day
  • Be willing to sign informed consent and undergo initial assessment and follow-up
  • Be willing to provide at least one collateral contact and collateral contact information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00109460

United States, California
SPIRITT Family Services
La Puente, California, United States
United States, Massachusetts
Athol Behavioral Health Center
Athol, Massachusetts, United States, 01331
United States, Michigan
Home of New Vision
Ann Arbor, Michigan, United States, 48104
New Life Home for Recovering Women, Inc
Detroit, Michigan, United States
United States, New York
Brooklyn Psychiatric Centers
Brooklyn, New York, United States
North General Hospital
New York, New York, United States
United States, Vermont
Maple Leaf Counseling, Inc.
Montpelier, Vermont, United States
Sponsors and Collaborators
Inflexxion, Inc.
National Institute on Drug Abuse (NIDA)
Principal Investigator: Stephen F Butler, Ph.D. Inflexxion, Inc.

Responsible Party: Inflexxion, Inc.
ClinicalTrials.gov Identifier: NCT00109460     History of Changes
Other Study ID Numbers: NIDA-80460-1
R44DA080460 ( U.S. NIH Grant/Contract )
First Posted: April 28, 2005    Key Record Dates
Last Update Posted: May 13, 2015
Last Verified: May 2015

Keywords provided by Inflexxion, Inc.:

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders